| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |